CYTOCLONAL PHARMACEUTICS INC /DE
10-Q, EX-27, 2000-11-14
PHARMACEUTICAL PREPARATIONS
Previous: CYTOCLONAL PHARMACEUTICS INC /DE, 10-Q, 2000-11-14
Next: TARRANT APPAREL GROUP, 10-Q, 2000-11-14



<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JUL-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          36,472
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                36,817
<PP&E>                                           1,084
<DEPRECIATION>                                     470
<TOTAL-ASSETS>                                  38,411
<CURRENT-LIABILITIES>                              906
<BONDS>                                              0
                                0
                                          7
<COMMON>                                           158
<OTHER-SE>                                      36,559
<TOTAL-LIABILITY-AND-EQUITY>                    38,411
<SALES>                                              0
<TOTAL-REVENUES>                                    67
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                 2,553
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   1
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (2,003)
<EPS-BASIC>                                    (.13)
<EPS-DILUTED>                                    (.13)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission